Clinical Trials List
2007-11-15 - 2008-06-30
Phase II
Terminated23
Study ended1
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 姚建安 Division of Family Medicine
- 孔祥琪 Division of Infectious Disease
- 陳世英 Division of Infectious Disease
- 程劭儀 Division of Family Medicine
- Shan-Chwen Chang Division of Infectious Disease
- 郭斐然 Division of Family Medicine
- Kuo-Chin Huang Division of Family Medicine
- 何雅淇 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- RONG -SAN JIANG Division of Otolaryngology
- 胡松原 Division of Emergency Medicine
- 蔡哲安 Division of Infectious Disease
- 張開明 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Te-Chun Hsia Division of Thoracic Medicine
- Chia-Der Lin Division of Otolaryngology
- 陳維恭 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Yingren Chen Division of Infectious Disease
- 楊建章 Division of Infectious Disease
- 林皇伸 Division of General Internal Medicine
- Ming-Hsun Lee Division of Infectious Disease
- 葉忠智 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 林健盛 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Wei-Ting Chang Division of Infectious Disease
- 王建楠 Division of Family Medicine
- 湯宏仁 Division of Infectious Disease
- 李璧伊 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Tsong-Yih Ou Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 馬瑞杉 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 鄭任勳 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
300 participants
-
Global
300 participants
